ABCG2 and central nervous system cancer: The results display that the expression ratios of the ABC transporters are distinctly different between glioma cells and GSCs before drug treatments, and the expression ratios of ABCB1, ABCC1 and ABCG2 in GSCs are down-regulated significantly after treatment with multifunctional targeting drugs-loaded liposomes (Fig. 5A).